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Available online 16 June 2016Diffusion tensor imaging (DTI) studies have provided evidence of widespreadwhite matter (WM) abnormalities
in schizophrenia. Although these abnormalities appear clinically signiﬁcant, the relationship to speciﬁc clinical
symptoms is limited and heterogeneous. This study examined the association between WM microstructure
and the severity of the ﬁvemain DSM-5 schizophrenia symptom dimensions. DTI wasmeasured in forty patients
with schizophrenia spectrum disorders. Using Tract-Based Spatial Statistics controlling for age, gender and anti-
psychotic dosage, our analyses revealed signiﬁcant negative relationships betweenWMmicrostructure and two
DSM-5 symptom dimensions: Whereas abnormal psychomotor behavior was particularly related to WM of
motor tracts, negative symptoms were associated with WMmicrostructure of the prefrontal and right temporal
lobes. However, we found no associations betweenWMmicrostructure and delusions, hallucinations or disorga-
nized speech. These data highlight the relevance of characteristic WM disconnectivity patterns as markers for
negative symptoms and abnormal psychomotor behavior in schizophrenia and provide evidence for relevant as-
sociations between brain structure and aberrant behavior.
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Schizophrenia is characterized by heterogeneous symptompatterns.
This heterogeneity has longbeen explained in terms of clinical subtypes,
as in the fourth edition of the Diagnostic and Statistical Manual of Men-
tal Disorders (DSM-IV) (Tandon et al., 2013). Because these subtypes
lack stability and biological correlates, they were eliminated and re-
placed by psychopathological dimensions in the DSM-5 (Barch et al.,
2013; Peralta and Cuesta, 2001). The main symptom dimensions of
schizophrenia in the DSM-5 are delusions, hallucinations, disorganized
speech, abnormal psychomotor behavior, and negative symptoms. The
DSM-5 schizophrenia dimensions allow describing the heterogeneity
of symptoms in a more valid, reliable and clinically useful way
(Tandon et al., 2013).
Brain white matter (WM) abnormalities have been reported as one
of the central hallmarks in schizophrenia; thought to contribute to the
pathophysiology of the disorder (Davis et al., 2003). Diffusion tensor im-
aging (DTI) is a non-invasive Magnetic Resonance Imaging (MRI)iatry, Bolligenstrasse 111, 3000
.
. This is an open access article undermethod that allows the investigation of WMmicrostructure by quanti-
fying the degree and direction of water diffusion (Basser, 1995; Mori et
al., 2005). A number of studies provide evidence ofWMabnormalities in
schizophrenia, predominantly in the prefrontal and temporal lobe,
using most often fractional anisotropy (FA) as an indicator of the integ-
rity of WM (Federspiel et al., 2006; Kubicki et al., 2007). Altered white
matter microstructure has been reported across the course of schizo-
phrenia, in subjects at risk for psychosis and in healthy ﬁrst-degree rel-
atives of schizophrenia patients, suggesting that these alterations are
associated both with the biological risk of schizophrenia and with
symptom progression (Federspiel et al., 2006; Fitzsimmons et al.,
2013; Ohtani et al., 2015).
Several studies have focused on the link between brain WM abnor-
malities and schizophrenia symptom dimensions. For example, conﬂict-
ing results were reported for WM associations with the classical
positive/negative symptom dimensions probably due to different patient
groups (Asami et al., 2014; Cheung et al., 2011; Roalf et al., 2015; Zhang et
al., 2016). For other symptom dimensions (e.g. disorganized speech, ab-
normal psychomotor behavior), only a few studies have investigated
the association with aberrant WM integrity (Asami et al., 2013; Bai et
al., 2009). In addition, cognitive impairment in schizophrenia was associ-
ated with WM microstructure in association ﬁbers such as the rightthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Demographic and clinical characteristics.
Variables M SD
Age (years) 37.20 10.40
Education (years) 13.53 3.10
Duration of illness (years) 11.77 11.05
Number of episodes 6.58 7.71
PANSS-Pos 18.25 6.48
PANSS-Neg 18.48 5.41
PANSS-Total 72.43 17.04
CPZ (mg) 411.70 358.47
PANSS, Positive and Negative Syndrome Scale; PANSS-Pos, subscale for positive symp-
toms; PANSS-Neg, subscale for negative symptoms; PANSS-Total, total score of PANSS;
CPZ, chlorpromazine equivalents;M=Mean; SD= Standard deviation.
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fronto-occipital fasciculus (Liu et al., 2013; Seitz et al., 2016; Zeng et al.,
2016). Given the heterogeneity of current results for some symptom di-
mensions and a lack of studies for others, the question remains whether
different dimensions of schizophrenia have speciﬁc brainWM correlates.
Applying the dimensional approach of the DSM-5 to schizophrenia psy-
chopathology may further help ﬁnding neural underpinnings of aberrant
behavior (Heckers et al., 2013). Therefore, we aimed to investigate for the
ﬁrst time the association betweenWMmicrostructure and all of the ﬁve
main DSM-5 dimensions in one group of patients with schizophrenia
spectrum disorders. We hypothesized in some of the ﬁve dimensions an
association between symptom severity and WM alteration, particularly
in the dimension of abnormal psychomotor behavior, as aberrant motor
behavior was consistently linked to WM abnormalities in schizophrenia
before (Bracht et al., 2013; Walther et al., 2011).
2. Material and methods
2.1. Participants
Forty patients (25 men, 15 women) with schizophrenia (77.5%),
schizophreniform (17.5%) or schizoaffective disorder (5%) were includ-
ed in the study. All patients were recruited from the inpatient and out-
patient departments of the University Hospital of Psychiatry Bern,
Switzerland. They were right-handed as determined by the Edinburgh
handedness inventory (Oldﬁeld, 1971).
Inclusion criteria were diagnoses of schizophrenia, schizoaffective
disorder or schizophreniform disorder according to the Diagnostic and
Statistical Manual of Mental Disorders, ﬁfth edition. Exclusion criteria
were any substance-related addiction other than nicotine, a past or cur-
rent medical or neurological condition associated with either impaired
or aberrant movement or WM abnormalities (e.g. stroke, multiple scle-
rosis), histories of head traumawith loss of consciousness or electrocon-
vulsive treatment and speciﬁc exclusion criteria for MRI scans (e.g.
metallic implants, pregnancy and claustrophobia).
The severity of each core domain of the DSM-5 schizophrenia symp-
tom dimensions was rated on a ﬁve-point scale ranging from 0 (not
present) to 4 (present and severe) (Barch et al., 2013). Dimensional rat-
ings of the severity in our groupwere: delusions (M=2.18±1.26), hal-
lucinations (M= 1.3 ± 1.51), disorganized speech (M= 1.63 ± 1.37),
abnormal psychomotor behavior (M = 1.53 ± 1.52) and negative
symptoms (M = 2.2 ± 1.09). Correlations between the ﬁve symptom
dimensions were calculated using Spearman rank correlations. Addi-
tional assessments included theMini International Neuropsychiatric In-
terview (MINI) (Sheehan et al., 1998) and the Comprehensive
Assessment of Symptoms and History (CASH) (Andreasen et al., 1992)
to establish diagnoses and the Positive and Negative Syndrome Scale
(PANSS) (Kay et al., 1987) for schizophrenia psychopathology. All but
three patients received antipsychotic pharmacotherapy. Chlorproma-
zine equivalent dosages (CPZ) were calculated to evaluate current anti-
psychotic exposure (Woods, 2003). The demographic and clinical
characteristics of the participants are summarized in Table 1.
The protocol was approved by the local ethics committee (KEK-BE
025/13) and adhered to the Declaration of Helsinki. All participants re-
ceived oral and written information on the planned study. The capacity
of the patients to give informed consentwas conﬁrmed by their treating
psychiatrist. All participants provided written informed consent.
2.2. MRI acquisition
Imaging was performed on a 3 T MRI scanner (Siemens Magnetom
Trio; SiemensMedical Solutions, Erlangen, Germany)with a 12-channel
radio frequency headcoil for signal reception. For DTI measurements,
we used a spin echo planar imaging (EPI) sequence (59 slices, FOV =
256 × 256 mm2, sampled on a 128 × 128 matrix, slice thickness =
2 mm, gap between slices = 0 mm, resulting in 2 mm3 isotopic voxelresolution) and TR/TE = 8000/92 ms covering the whole brain
(40 mT/m gradient, 6/8 partial Fourier, GRAPPA factor 2, bandwidth
1346 Hz/Px). Diffusion-weighted images (DWI) were positioned in
the axial plane parallel to the AC-PC line and measured along 42 direc-
tions with a b-value = 1300 s/mm2. The sequence included 4 images
without diffusion weighting (e.g. b-value = 0 s/mm2; the ﬁrst and
every subsequent 12th image). We used a balanced and rotationally in-
variant diffusion-encoding scheme over the unit sphere to generate the
DTI data. Acquisition time was 6 min.
2.3. DTI processing
DTI analyses were processed using the FMRIB (Functional Magnetic
Resonance Imaging of the Brain's diffusion toolbox) Software Library
(FSL) (FSL, http://www.fmrib.ox.ac.uk/fsl), including the Tract-Based
Spatial Statistics (TBSS) software (Smith et al., 2006; Smith et al.,
2004). The images of each subject were ﬁrst corrected for head move-
ments andeddy currents (using “eddy-tool” of FSL). FA imageswere cre-
ated by ﬁtting a tensor model to the raw data (using “FDT”) and then a
brain extraction tool was applied (using “BET-tool” of FSL) (Smith,
2002). All subjects' FA datawere aligned to a 1mm3Montreal Neurolog-
ical Institute (MNI) standard space. The alignment was performed ap-
plying FMRIB's Non-Linear Image Registration Tool (Andersson et al.,
2007a; Andersson et al., 2007b), which uses a b-spline representation
of the registration warp ﬁeld (Rueckert et al., 1999). A mean FA image
was prepared and thinned in order to create a mean FA skeleton for
later group comparisons. Toprevent the inclusion of non-skeletal voxels,
we used a FA threshold of 0.2. Each subject's aligned FA data was then
projected onto the skeleton. The resulting data was subjected to voxel-
wise between subject statistics. Additionally to the FA images, other pa-
rameters of DTI, mean diffusivity (MD), radial diffusivity (RD) and axial
diffusivity (AD) were calculated by ﬁtting a tensor model to the data at
each voxel. In order to use TBSS inMD, RD and AD images, the nonlinear
warps and skeleton projection of the FA images were applied to MD, RD
and AD images using the “non_fa” option.
2.4. Statistical analysis
Statistical analyses for WM microstructure were carried out with
TBSS, which is based on a non-parametric approach using permutation
test theory with a general linear model (GLM) design matrix (Smith et
al., 2006). Age, gender and chlorpromazine equivalents were entered
as covariates of no interest into the analyses. Within the GLM frame-
work, we examined the association between each of the ﬁve symptom
dimensions with FA, MD, RD and AD.
Skeletonised FA, MD, RD and AD were tested voxelwise for associa-
tions with DSM-5 dimensions using a randomise tool (Winkler et al.,
2014) (5000 permutations) with a threshold-free cluster enhancement
(TFCE) correction method (Smith and Nichols, 2009). A TFCE corrected
p-value b 0.05 (FWE corrected) was considered statistically signiﬁcant
in all of the analyses. The resulting signiﬁcant skeletal regions were lo-
cated and labelled by mapping the corrected statistical map to the
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JHU-WM tractography atlas in MNI space (Mazziotta et al., 2001; Mori
et al., 2005). All clusters exceeding 50 voxels per WM region were
displayed.
3. Results
The correlations between behavioral ratings of the DSM-5 dimen-
sions are summarized in Table 2. In two out of ﬁve dimensions, i.e. ab-
normal psychomotor behavior and negative symptoms, the severity of
symptoms was speciﬁcally associated with WM brain structure. In con-
trast, we found no positive or negative linear relationship betweenWM
microstructure and delusions (p ≥ 0.074), hallucinations (p ≥ 0.247) and
disorganized speech (p ≥ 0.14). FA differences between schizophrenia
patients and matched controls are given in the supplemental material.
In short, patients had reduced FA in bilateral clusters within the corpus
callosum, anterior limb of the internal capsule, corona radiata, anterior
and posterior thalamic radiation, corticospinal tract, aswell as in the su-
perior and inferior longitudinal fasciculi.
3.1. Linear relationship of white matter microstructure and motor
dimension
The GLM applied in TBSS showed a signiﬁcant negative linear rela-
tionship between the severity scores of the DSM-5 motor dimension
and WMmicrostructure in predominantly motor tracts (see Fig. 1 and
Table 3). Negative correlation was observed between FA and severity
of the motor dimension in the superior and inferior longitudinal fascic-
ulus, internal and external capsule and corpus callosum (p b 0.05, FWE
corrected). Moreover, increased severity of the motor dimension was
positively associated with increased RD (p b 0.05, FWE corrected) in
similar regions of the frontal lobe (see Table 3). No associations with
MD (p ≥ 0.101) and AD (p ≥ 0.386) were detected. All clusters with sig-
niﬁcant correlations of FA and the motor dimension were also found to
have reduced FA in schizophrenia compared to healthy controls, except
for the cluster within the left sagittal stratum and the right external
capsule.
3.2. Linear relationship of white matter microstructure and negative symp-
tom dimension
The GLM revealed a signiﬁcant negative linear relationship between
WM microstructure and the severity scores of the DSM-5 negative
symptom dimension (see Fig. 2 and Table 4). Low FA values were asso-
ciated with increased negative symptoms (p b 0.05, FWE corrected) in
predominantly prefrontal clusters of the corona radiata, internal and ex-
ternal capsule and inferior fronto-occipital fasciculus. In addition, in-
creased negative symptoms were associated with increased RD
(p b 0.05, FWE corrected) in the corpus callosum and the anterior coro-
na radiata (see Table 4). In contrast, MD (p ≥ 0.158) and AD (p ≥ 0.170)
were not associatedwith the negative symptomdimension. Someof the
clusters with signiﬁcant association between FA and negative symptom
severity were not detected in the group contrast (controls N patients,
see supplemental material). These unique clusters include the cerebral
peduncle, the right posterior limb of the internal capsule, sagittalTable 2
Correlations between the DSM-5 symptom dimensions.
Abnormal psychomotor behavior
Negative symptoms 0.509⁎⁎
Delusions −0.071
Hallucinations 0.205
Disorganized speech −0.064
Spearman's rho correlation coefﬁcient.
⁎ Correlation is signiﬁcant at the 0.05 level (2-tailed).
⁎⁎ Correlation is signiﬁcant at the 0.01 level (2-tailed).stratum, the bilateral external capsule and uncinate fasciculus. Howev-
er, bilateral clusters in the corpus callosum, corona radiata, anterior tha-
lamic radiation and inferior fronto-occipital fasciculus overlap with
those detected in the group comparison (see Supplemental material).
4. Discussion
This is the ﬁrst study examining the associations of all ﬁve main
DSM-5 schizophrenia symptom dimensions with WM microstructure
in one group of patients with schizophrenia spectrum disorders. The re-
sults indicated characteristic patterns of WMmicrostructure linked to
the severity of two DSM-5 schizophrenia symptom dimensions, i.e. ab-
normal psychomotor behavior and negative symptoms. WM integrity
was associated with abnormal psychomotor behavior predominantly
in motor tracts and with negative symptoms mainly in frontal regions.
Motor abnormalities are frequent in schizophrenia, but insufﬁciently
studiedwith neuroimagingmethods (Walther, 2015;Walther and Strik,
2012). Previous studies demonstrated an association of the activity level
as a measure of motor behavior with WM regions underneath the sup-
plementalmotor area, precentral gyrus, cingulum andwith connections
between the primary motor cortex and subcortical structures and be-
tween the pre-SMA and other motor areas in patients with schizophre-
nia (Bracht et al., 2013; Walther et al., 2011). Furthermore, a DTI study
in patients with schizophrenia reported correlations between dyskine-
sia severity and FA in WM surrounding the inferior and medial frontal
gyrus, the basal ganglia and the somatosensory cortex (Bai et al.,
2009). Thus, our result of WM alterations in schizophrenia patients
with pronounced abnormal psychomotor behavior is in accordance
with previous DTI studies and emphasizes the role of WM
disconnectivity in motor pathways in disturbed motor behavior in
schizophrenia (Walther, 2015).
Our results also conﬁrm those of other DTI studies reporting associ-
ations between negative symptoms and WMmicrostructure in schizo-
phrenia. Increased severity of negative symptoms measured by the
Scale for the Assessment of Negative Symptoms (SANS) (Andreasen,
1989) was related to reduced WM integrity in the frontal lobe, corpus
callosum, uncinate fasciculus, anterior thalamic radiation, inferior
fronto-occipital fasciculus and superior longitudinal fasciculus (Asami
et al., 2014; Nakamura et al., 2012; Szeszko et al., 2008; Zeng et al.,
2016). Furthermore, WMmicrostructure in the splenium of the corpus
callosum, the retrolenticular limb and posterior limb of the internal cap-
sule have previously been associated with negative symptoms (Arnedo
et al., 2015). Additionally, ﬁbertracking studies revealed correlations of
negative symptoms with WM connections between the ventral teg-
mental area and the amygdala, the nucleus accumbens and the
orbitofrontal cortex and between the anterior cingulate cortex and the
orbitofrontal cortex (Bracht et al., 2014; Ohtani et al., 2014; Ohtani et
al., 2015). Contrary, there is one study of never-medicated ﬁrst episode
schizophrenia patients, which found no correlations between FA and
negative symptoms (Cheung et al., 2011). However, this might be due
to the fact that negative symptoms become more prominent at an ad-
vanced stage of the illness (Fenton and McGlashan, 1991). In line with
the literature, we found reduced FA values in widespread WM regions
of the frontal and temporal lobes in schizophrenia patients with prom-
inent negative symptoms. This indicates that disruption of connectivityNegative symptoms Delusions Hallucinations
– – –
0.100 – –
0.342⁎ 0.347⁎ –
−0.121 0.107 0.071
Fig. 1.Relationship of whitemattermicrostructure and abnormal psychomotor behavior. The TBSS image shows the negative linear relationship between the severity of the DSM-5motor
dimension and FA values within the areas indicated in red at p b 0.05, FWE corrected. Z and x indicate the coordinates of the image slices in mm.
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opment of negative symptoms in schizophrenia (Khadka et al., 2013;
Orliac et al., 2013; Venkataraman et al., 2012).
Some overlap was noted between the associations of FA and motor
behavior and those of FA and negative symptoms, e.g. in the corpusTable 3
Location of signiﬁcant relationship betweenwhitemattermicrostructure (FA, RD) and ab-
normal psychomotor behavior.
Location Center of gravity (mm
coordinates)
Cluster
size
p (FWE
corrected)
x y z
FA (negative linear relationship)
Genu of corpus callosum 0.20 27.71 6.86 817 0.039
Body of corpus callosum −3.07 10.05 26.02 530 0.040
Splenium of corpus callosum 19.49 −42.08 26.76 119 0.049
Anterior limb of internal capsule R 19.15 9.30 9.24 348 0.038
Anterior corona radiata R 21.14 29.85 11.17 988 0.032
Anterior corona radiata L −18.32 31.24 10.76 593 0.042
Superior corona radiata R 24.91 1.66 28.29 302 0.034
Superior corona radiata L −17.62 8.96 34.84 117 0.042
Posterior thalamic radiation L −33.07 −57.91 5.61 363 0.046
Sagittal stratum (include inferior
longitudinal fasciculus and
inferior fronto-occipital
fasciculus) L
−39.12 −41.68 −6.57 75 0.046
External capsule R 29.78 4.77 10.84 69 0.037
Anterior thalamic radiation R 19.53 19.21 7.80 322 0.035
Anterior thalamic radiation L −24.38 33.11 9.31 55 0.046
Forceps major −25.61 −67.39 13.91 69 0.045
Forceps minor −1.24 36.55 6.67 1450 0.038
Inferior fronto-occipital
fasciculus R
26.57 31.49 4.61 237 0.031
Inferior fronto-occipital
fasciculus L
−32.61 −23.00 1.50 249 0.047
Inferior longitudinal fasciculus L −36.51 −52.31 −0.34 194 0.047
Superior longitudinal fasciculus R 35.85 −21.92 32.11 566 0.036
RD (positive linear relationship)
Genu of corpus callosum 2.05 29.60 10.74 200 0.049
Body of corpus callosum −1.27 13.82 25.77 239 0.047
Anterior limb of internal capsule R 20.31 10.45 10.85 75 0.050
Anterior corona radiata R 21.88 27.17 15.61 586 0.045
Anterior corona radiata L −17.43 27.87 21.17 167 0.049
Superior corona radiata R 21.06 10.62 31.27 89 0.044
Anterior thalamic radiation R 21.42 24.17 10.37 109 0.048
Forceps minor 6.96 36.70 11.12 445 0.047
Inferior fronto-occipital
fasciculus R
26.48 31.79 4.65 151 0.049
Superior longitudinal fasciculus R 34.27 −36.97 33.83 106 0.047callosum, corona radiata and the anterior limb of the internal capsule.
This is not surprising as negative symptoms and motor symptoms
often correlate at a descriptive level in schizophrenia (Walther and
Strik, 2012), e.g. avolition contributes to reduced motor activity (Docx
et al., 2013; Walther et al., 2015). In line with this, we found a strong
correlation of the DSM-5 ratings for abnormal psychomotor behavior
and negative symptoms in patients (see Table 2). Despite this behavior-
al overlap and shared associations of symptoms and WM microstruc-
ture in the anterior corona radiata and corpus callosum, there are
clear differences between theWM associations of the two symptom di-
mensions: associations of FA with abnormal psychomotor behavior in-
cluded right parietal and frontal clusters, whereas FA was associated
in the posterior limb of internal capsule and temporal clusterswith neg-
ative symptoms.
WMmicrostructure in theprefrontal and temporal lobe are often ab-
errant in schizophrenia (Federspiel et al., 2006; Kubicki et al., 2007). Our
results are in linewith theseﬁndings. In fact, we found reduced FA in the
corpus callosum, corona radiata, internal capsule, inferior-fronto-occip-
ital fasciculus and superior and inferior longitudinal fasciculus in pa-
tients compared to controls (see Supplementary Figure and Table).
The clusters with group differences partially overlap with the associa-
tions between symptom ratings and WMmicrostructure. Therefore, a
proportion of the associations with symptoms are located in areas
with aberrant WMmicrostructure in schizophrenia. The inverse associ-
ations of FA and symptom severity indicate that patients with increased
symptom severity in the investigated dimensions had the lowest FA
values. This is in linewith the groupdifference of reduced FA in patients.
However, some of the detected clusters seem to be uniquely associated
with symptom severity, such as bilateral external capsule, the posterior
internal capsule and the uncinate fasciculus.
We found no signiﬁcant associations between WMmicrostructure
and the other three main symptom dimensions, delusions, hallucina-
tions and disorganized speech. There are at least three reasons that
might explain these ﬁndings. First, it is highly probable that the con-
structs behind these three DMS-5 dimension ratings are too complex
to be mapped on brain structure because they include various underly-
ing components. Second, the dimensions share less temporal stability
compared to the motor and negative symptom dimensions. Therefore,
a simple linear relationship with cerebral structure might not be an ad-
equate way of investigating the neural basis of these dimensions,
though functional correlates such as resting state perfusion proved suit-
able (Pinkham et al., 2015). Finally, the dimensions of abnormal
psychomotor behavior and negative symptoms are not limited to the
patients' symptom report but rely substantially on signs. Thus, the latter
two symptom dimensions may have more validity.
Fig. 2. Relationship of white matter microstructure and negative symptoms. The TBSS image shows the negative linear relationship between the severity of the DSM-5 negative symptom
dimension and FA values within the areas indicated in red at p b 0.05, FWE corrected. Z and x indicate the coordinates of the image slices in mm.
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WM correlates of positive symptoms in schizophrenia. Several studies
found associations between delusions or hallucinations and WMTable 4
Location of signiﬁcant relationship between white matter microstructure (FA, RD) and
negative symptoms.
Location Center of gravity (mm
coordinates)
Cluster
size
p (FWE
corrected)
x y z
FA (negative linear relationship)
Genu of corpus callosum 1.07 28.34 8.24 1119 0.024
Body of corpus callosum 0.33 6.84 27.29 728 0.031
Cerebral peduncle R 17.41 −17.46 −8.22 155 0.043
Anterior limb of internal capsule R 18.40 8.11 8.42 530 0.024
Anterior limb of internal capsule L −17.55 12.05 6.09 331 0.033
Posterior limb of internal
capsule R
21.58 −11.40 7.74 360 0.032
Retrolenticular part of internal
capsule R
32.07 −27.06 5.23 308 0.029
Anterior corona radiata R 21.74 29.88 9.53 975 0.024
Anterior corona radiata L −19.31 30.78 9.29 906 0.025
Superior corona radiata R 24.08 −2.38 26.93 283 0.033
Superior corona radiata L −17.53 8.51 35.17 122 0.025
Posterior thalamic radiation R 33.22 −41.66 12.29 65 0.041
Sagittal stratum (include inferior
longitudinal fasciculus and
inferior fronto-occipital
fasciculus) R
38.87 −20.12 −8.27 107 0.029
External capsule R 31.53 0.42 −0.02 580 0.031
External capsule L −27.88 13.29 −5.06 248 0.028
Fornix R 30.35 −23.37 −6.53 118 0.027
Anterior thalamic radiation R 18.17 14.22 6.81 449 0.025
Anterior thalamic radiation L −19.73 18.39 7.95 399 0.031
Corticospinal tract R 20.65 −17.40 −0.22 220 0.041
Forceps minor 0.78 36.96 9.31 2124 0.024
Inferior fronto-occipital
fasciculus R
31.48 3.73 −0.92 736 0.028
Inferior fronto-occipital
fasciculus L
−25.20 24.10 2.53 230 0.028
Uncinate fasciculus R 30.71 8.98 −9.47 86 0.029
Uncinate fasciculus L −29.67 9.01 −7.37 83 0.029
RD (positive linear relationship)
Genu of corpus callosum 0.60 29.02 9.20 538 0.047
Body of corpus callosum −10.53 10.01 28.51 146 0.048
Anterior corona radiata R 18.61 32.52 14.48 338 0.045
Anterior corona radiata L −17.87 31.21 14.19 354 0.047
Superior corona radiata L −17.17 10.74 34.75 69 0.047
Forceps minor 2.44 38.75 9.59 1361 0.047microstructure in the arcuate fasciculus, cingulate bundle, corpus
callosum, superior longitudinal fasciculus, inferior fronto-occipital fas-
ciculus and the connection between the amygdala and the nucleus ac-
cumbens (Bracht et al., 2014; Hubl et al., 2004; Seok et al., 2007;
Szeszko et al., 2008). In addition, recent studies found associations of
hallucination and delusion severity with WM microstructure in the
right inferior longitudinal fasciculus and the connection between the
right posteriormiddle orbitofrontal cortex and the rostral part of the an-
terior cingulate cortex (Ohtani et al., 2015; Seitz et al., 2016). Only for
delusions researchers found associations with WM properties in the
cingulum bundle (Whitford et al., 2015), fornix and external capsule
(Arnedo et al., 2015). Moreover, changes in WM microstructure of the
left longitudinal fasciculus have recently been shown to correlate with
improvements of positive symptoms (Zeng et al., 2016). However,
there are other studies showing no associations of positive symptoms
in schizophrenia and WMmicrostructure (Asami et al., 2014; Spalletta
et al., 2013; Wolf et al., 2014). Regarding disorganized speech, only
very few studies investigated the association with WMmicrostructure
and found correlates in the middle and inferior longitudinal fasciculus
(Asami et al., 2013; Phillips et al., 2009).
The observed heterogeneity of ﬁndings regarding WM and positive
symptoms in the literature may originate from multiple factors, such
as a wide range of methodological differences concerning the sample
size, image analysis techniques, statistical techniques, subject character-
istics and the heterogeneity of schizophrenia. More research is needed
to disentangle the inconsistency of WM correlates of delusions and
hallucinations and to conﬁrm the preliminary results regarding disorga-
nized speech.
Some limitations of the present study require discussion. First, some
variables may inﬂuence WMmicrostructure. Almost all schizophrenia
patientswere treatedwith antipsychoticmedication. Although previous
studies found no effect of exposure to antipsychotic medication onWM
structure (Kanaan et al., 2009; Peters et al., 2010) orWMdisconnection
in never medicated chronic schizophrenia patients (Liu et al., 2013),
other studies show an effect of antipsychotic exposure on free radicals
from activated microglia and on the release of inﬂammatory cytokines
or lower astrocyte numbers in monkeys (Konopaske et al., 2008;
Monji et al., 2009). Likewise, age may affect frontal and parietal WM
structure (Davis et al., 2009; Gunning-Dixon et al., 2009; Salat et al.,
2005). Age related WM changes occur in schizophrenia patients and
healthy controls (HC), although in schizophrenia, FA impairments
appear early in life and are permanently reduced compared to HC
(Chiapponi et al., 2013). In addition, gender has previously been
shown to affect WMmicrostructure in the corpus callosum, cingulum,
98 P.V. Viher et al. / NeuroImage: Clinical 12 (2016) 93–99cerebellar peduncle and superior longitudinal fasciculus (Kanaan et al.,
2012; Kanaan et al., 2014; Menzler et al., 2011). Therefore, we entered
chlorpromazine equivalents, age and gender as variables of no interest
into all analyses. Second, the exact association betweenWM abnormal-
ities and cross-sectional symptomatology bears some uncertainty.
WhileWMalterations are considered relatively stable over time, symp-
tom severity maywax andwane. Clearly, longitudinal studies in clinical
populations may shed further light on this issue. However, given that
WM microstructure contributes to functional connectivity of relevant
brain areas, the association between brain structure and behavior is bi-
ologically plausible. This is particularly true for the motor dimension in
which a deﬁned cortico-subcortical loop is associated with the behav-
ioral output (Walther, 2015).
In summary, the present study revealed characteristic patterns of
WM alterations that were associatedwith the severity of abnormal psy-
chomotor behavior and negative symptoms. These two DSM-5 symp-
tom dimensions share brain-behavior associations and thus argue for
pathobiological plausibility of the DSM-5 symptom dimensions in
schizophrenia. Strikingly, relatively simplemeasures of symptom sever-
ity corroborated ﬁndings acquired with sophisticated instruments. Fu-
ture studies could explore the longitudinal course of the
symptomatology in schizophrenia and their white matter correlates.
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